Evaluation of clinical efficacy of rabeprazole in chronic gastritis and impact on digestive function of patients
雷贝拉唑治疗慢性胃炎的临床疗效和对患者消化功能的影响评价

摘要

目的 分析慢性胃炎采取雷贝拉唑治疗产生的临床效果。方法 选择我院2020年2月到2021年2月接受的70例慢性胃炎患者为研究对象，将其均采取雷贝拉唑治疗。分析治疗效果。结果 患者治疗后消化功能评分明显降低于治疗前（P<0.05）为差异显著，有统计学意义。患者治疗后炎性因子水平明显降低于治疗前（P<0.05）为差异显著，有统计学意义。患者治疗后症状评分明显降低于治疗前（P<0.05）为差异显著，有统计学意义。患者治疗总有效率97.14%，不良反应发生率4.29%。患者治疗总有效率较高，不良反应发生率较低。结论 雷贝拉唑治疗慢性胃炎的临床疗效较佳，能够改善消化功能，加快症状恢复，并且用药安全性较高，值得临床重视并采纳。

Abstract

Objective To analyze the clinical effect of rabeprazole treatment in chronic gastritis.
Methods 70 patients with chronic gastritis received from February 2020 to February 2021 were selected as the study subjects and were treated with rabeprazole. Analyze the treatment effects.
Results The decreased decreased before treatment (P <0.05). The significant decrease of inflammatory factors after patients before treatment (P <0.05) was significant. The significant decrease in symptom scores than before treatment (P <0.05) was significant. The total response rate of the patients was 97.14%, and the incidence of adverse reactions was 4.29%. Patients have a higher overall response rate and a low incidence of adverse reactions.
Conclusion   The clinical effect of rabeprazole in chronic gastritis is better, which can improve digestive function, accelerate the recovery of symptoms, and the drug safety is high, which is worthy of clinical attention and adoption.